logo

For the Inventor, By the Inventor

Bronx, NY, United States of America

Stoyan S Bardarov

This inventor holds 6 USPTO granted patents. Top assignees: Albert Einstein College of Medicine, University of Pittsburgh, Other. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stoyan S Bardarov. Retrieved from https://idiyas.com/inventor/stoyan-s-bardarov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Bronx, NY (US) (1998 - 2010)
  • Worcester, MA (US) (2011)

Company Filing History:

goldMedal5 out of 513 
 
Albert Einstein College of Medicine
 patents
silverMedal3 out of 1,959 
 
University of Pittsburgh
 patents
bronzeMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2011

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8084041 - [object Object] (2011-12-27),
2. 7722861 - [object Object] (2010-05-25),
3. 6271034 - One step allelic exchange in mycobacteria using in vitro generated conditional transducing phages (2001-08-07),
4. 5994137 - L5 shuttle phasmids (1999-11-30),
5. 5972700 - TM4 conditional shuttle phasmids and uses thereof (1999-10-26),
6. 5750384 - L5 shuttle phasmids (1998-05-12),

Title: Stoyan S Bardarov: Innovator in Mycobacterial Research

Introduction

Stoyan S Bardarov is a prominent inventor based in Bronx, NY (US). He has made significant contributions to the field of mycobacterial research, holding a total of 6 patents. His innovative work focuses on methods and vaccines for treating mammals deficient in specific lymphocytes.

Latest Patents

Among his latest patents, Bardarov has developed methods for treating mammals that are deficient in CD4 and/or CD8 lymphocytes. These methods involve inoculating the mammal with an attenuated mycobacterium, which has been modified to exhibit reduced virulence. Additionally, he has created non-naturally occurring mycobacteria that have deletions in specific regions, leading to attenuated virulence compared to their non-modified counterparts. These advancements also include the development of vaccines that utilize these modified mycobacteria to protect mammals from virulent strains.

Career Highlights

Bardarov has worked with esteemed institutions such as the Albert Einstein College of Medicine and the University of Pittsburgh. His research has significantly advanced the understanding of mycobacterial infections and potential treatments.

Collaborations

Throughout his career, Bardarov has collaborated with notable scientists, including William R Jacobs, Jr. and Graham F Hatfull. These partnerships have further enriched his research and contributions to the field.

Conclusion

Stoyan S Bardarov is a key figure in mycobacterial research, with a focus on innovative treatments and vaccines. His work continues to impact the medical community and offers hope for improved therapies for lymphocyte deficiencies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…